Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP427925.RAabF-UI00CiZZcX_79bq6D_Dm-nN50otVLp0kWsPXfMk130_assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427925.RAabF-UI00CiZZcX_79bq6D_Dm-nN50otVLp0kWsPXfMk130_provenance.
• assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP645181.RAWjf2jUB9H7sQw39UbJ1c-ic7KV8S4khjphGYYf60Zlo130_assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645181.RAWjf2jUB9H7sQw39UbJ1c-ic7KV8S4khjphGYYf60Zlo130_provenance.
• NP645179.RAkxkehHphQ9p4xzrzFGJEClpLeDDrBQspGWIeV4E8XGU130_assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645179.RAkxkehHphQ9p4xzrzFGJEClpLeDDrBQspGWIeV4E8XGU130_provenance.
• NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
• NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.